参考文献/References:
[1] Kalra S,Singal A,Lathia T.What's in a name? redefining type 2 diabetes remission[J].Diabetes Ther,2021,12(3):647-654.DOI:10.1007/s13300-020-00990-z.
[2] Herdzik E,Safranow K,Ciechanowski K,et al.Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance[J].Pol Merkur Lekarski,2002,13(76):316-320.
[3] Buse JB,Caprio S,Cefalu WT,et al.How do we define cure of diabetes[J].Diabetes Care,2009,32(11):2133-2135.DOI:10.2337/dc09-9036.
[4] 中华医学会糖尿病学分会肥胖与糖尿病学组.2型糖尿病代谢手术术后管理中国专家共识[J].中华糖尿病杂志,2018,10(3):161-167.DOI:10.3760/cma.j.issn.1674-5809.2018.03.001.
[5] Nagi D,Hambling C,Taylor R.Remission of type 2 diabetes:a position statement from the Association of British Clinical Diabetologists(ABCD)and the Primary Care Diabetes Society(PCDS)[J].British J Diabetes,2019,19(1):73-76.DOI:10.15277/bjd.2019.221.
[6] Riddle MC,Cefalu WT,Evans PH,et al.Consensus report:definition and interpretation of remission in type 2 diabetes[J].Diabetologia,2021,Online ahead of print.DOI:10.1007/s00125-021-05542-z.
[7] Steven S,Hollingsworth KG,AL-Mrabeh A,et al.Very low-calorie diet and 6 months of weight stability in type 2 diabetes:pathophysiological changes in responders and nonresponders[J].Diabetes Care,2016,39(5):808-815.DOI:10.2337/dc15-1942.
[8] Taylor R,Barnes AC.Can type 2 diabetes be reversed and how can this best be achieved? James Lind Alliance research priority number one[J].Diabet Med,2019,36(3):308-315.DOI:10.1111/dme.13851.
[9] Lean ME,Leslie WS,Barnes AC,et al.Primary care-led weight management for remission of type 2 diabetes(DiRECT):an open-label,cluster-randomised trial [J].Lancet,2018,391(10120):541-551.DOI:10.1016/S0140-6736(17)33102-1.
[10] Lean MEJ,Leslie WS,Barnes AC,et al.Durability of a primary care-led weight-management intervention for remission of type 2 diabetes:2-year results of the DiRECT open-label,cluster-randomised trial[J].Lancet Diabetes Endocrinol,2019,7(5):344-355.DOI:10.1016/S2213-8587(19)30068-3.
[11] IIkova H,Glaser B,Tunçkale A,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment [J].Diabetes Care,1997,20(9):1353-1356.DOI:10.2337/diacare.20.9.1353.
[12] Li Y,Xu W,Liao Z,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J].Diabetes Care,2004,27(11):2597-2602.DOI:10.2337/diacare.27.11.2597.
[13] Xu W,Li YB,Deng WP,et al.Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients:a long-term follow-up study[J].Chin Med J(Engl),2009,122(21):2554-2559.DOI:10.3760/cma.j.issn.0366-6999.2009.21.006.
[14] Weng J,Li Y,Xu W,et al.Effect of intensive insulin therapy on beta-cell function and glycemic control in patients with newly diagnosed type 2 diabetes:a multicentre randomised parallel-group trial[J].Lancet,2008,371(9626):1753-1760.DOI:10.1016/S0140-6736(08)60762-X.
[15] Douros JD,Tong J,D'alessio DA.The Effects of bariatric surgery on islet function,insulin secretion,and glucose control[J].Endocr Rev,2019,40(5):1394-1423.DOI:10.1210/er.2018-00183.
[16] Dixon JB,O'Brien PE,Playfair J,et al.Adjustable gastric banding and conventional therapy for type 2 diabetes:a randomized controlled trial[J].JAMA,2008,299(3):316-323.DOI:10.1001/jama.299.3.316.
[17] Schauer PR,Kashyap SR,Wolski K,et al.Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J].N Engl J Med,2012,336(17):1567-1576.DOI:10.1056/NEJMoa1200225.
[18] Schauer PR,Bhatt DL,Kirwan JP,et al.STAMPEDE Investigators.Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes[J].N Engl J Med,2014,370(21):2002-2013.DOI:10.1056/NEJMoa1401329.
[19] Helmiö M,Victorzon M,Ovaska J,et al.Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity:a prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up[J].Scand J Surg,2014,103(3):175-181.DOI:10.1177/1457496913509984.
[20] Kramer CK,Zinman B,Retnakaran R.Short-term intensive insulin therapy in type 2 diabetes mellitus:a systematic review and meta-analysis[J].Lancet Diabetes Endocrinol,2013,1(1):28-34.DOI:10.1016/S2213-8587(13)70006-8.
[21] Arora T,Seyfried F,Docherty NG,et al.Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass[J].ISME J,2017,11(9):2035-2046.DOI:10.1038/ismej.2017.70.
[22] Taylor R,Al-Mrabeh A,Sattar N.Understanding the mechanisms of reversal of type 2 diabetes[J].Lancet Diabetes Endocrinol,2019,7(9):726-736.DOI:10.1016/s2213-8587(19)30076-2.
[23] Basso N,Soricelli E,Castagneto-Gissey L,et al.Insulin resistance,microbiota,and fat distribution changes by a new model of vertical sleeve gastrectomy in obese rats[J].Diabetes,2016,65(10):2990-3001.DOI:10.2337/db16-0039.
[24] Pérez-Pevida B,Escalada J,Miras AD,et al.Mechanisms underlying type 2 diabetes remission after metabolic surgery[J].Front Endocrinol(Lausanne),2019,10:641.DOI:10.3389/fendo.2019.00641.
[25] Castagneto Gissey L,Casella Mariolo J,Mingrone G.Intestinal peptide changes after bariatric and minimally invasive surgery:relation to diabetes remission[J].Peptides,2018,100:114-122.DOI:10.1016/j.peptides.2017.12.010.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(06):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(06):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(06):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(06):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(06):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(06):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]杨雪,何志伟,陈煜,等.2型糖尿病缓解:来自美国生活方式医学会的立场
声明(2020)和专家共识(2022)——解读与思考[J].国际内分泌代谢杂志,2023,43(02):195.[doi:10.3760/cma.j.cn121383-20221012-10021]
Yang Xue,He Zhiwei,Chen Yu,et al.Remission of type 2 diabetes mellitus: position statement from the American Society of Lifestyle Medicine(2020)and Expert Consensus(2022)—interpretation and reflections[J].International Journal of Endocrinology and Metabolism,2023,43(06):195.[doi:10.3760/cma.j.cn121383-20221012-10021]